Logo image
Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response
期刊文章   同儕審查

Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response

Yi‐Ru Pan, Chiao‐En Wu, Yu‐Chao Wang, Yi‐Chen Yeh, Meng‐Lun Lu, Yi‐Ping Hung, Yee Chao, Da‐Wei Yeh, Chien‐Hsing Lin, Jason Chia‐Hsun Hsieh, …
Clinical & translational immunology, 卷.9(7), 頁碼.e1145-n/a
2020
PMID: 32617161
Web of Science ID: WOS:000556914500008

摘要

Original
Immune checkpoint inhibitors (ICIs) have been widely used to treat various cancers and have achieved impressive success, resulting in a new era of anticancer therapy. However, only a subset of patients experienced lasting responses; therefore, exploring predictive biomarkers is critical to identify the patients who have benefit from ICIs. This gene panel using liquid biopsy is one of the best predictive biomarkers presently available and can help physicians to predict the response to ICIs and judge the utility of ICIs in clinical practice.

檔案與連結 (1)

url
https://doi.org/10.1002/cti2.1145檢視
已出版(紀錄版本) 開放

相關連結

詳細資料

Logo image